Recent News

• 09.16.2025 - Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
• 09.16.2025 - Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
• 09.16.2025 - Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
• 09.16.2025 - Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
• 09.12.2025 - Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
• 09.12.2025 - Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
• 09.12.2025 - Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
• 09.12.2025 - Les actionnaires de Theratechnologies approuvent le plan d’arrangement proposé visant l’acquisition de la Société par Future Pak
• 09.05.2025 - Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
• 09.05.2025 - Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

Recent Filings

• 09.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.17.2025 - EX-99.1 EX-99.1
• 09.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.12.2025 - EX-99.1 EX-99.1
• 09.12.2025 - EX-99.1 EX-99.1
• 09.05.2025 - EX-99.1 EX-99.1
• 09.05.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]